DELPHARM SAINT REMY

About DELPHARM SAINT REMY

Leading European contract manufacturer producing various forms of medicines with high quality, punctuality, and economic balance for global pharmaceutical labs.

Key facts

Industry

Pharmaceutical Manufacturing

Company size

51–250 employees

Headquarters

Saint-Rémy-sur-Avre, Centre-Val de Loire, France

Revenue

€26.2MFY2025, filed accounts, INPI

Website

delpharm.com

LinkedIn

linkedin.com/company/delpharm-saint-remy

DELPHARM SAINT REMY in the news

• Delpharm agrandit son site de Saint-Rémy-sur-Avre

  Delpharm invested 37 million euros in a new aseptic filling line at its Saint-Rémy-sur-Avre site to boost injectable vial production capacity.

  usinenouvelle.com · Jun 24, 2025
• Saint-Rémy-sur-Avre : Delpharm s’agrandit et embauche

  Expansion of the Saint-Rémy-sur-Avre facility with a 37 million euro investment to double production capacity and hire 60 technicians.

  evasionfm.com · Jun 19, 2025
• Delpharm consolide le milliard d’euros en 2023

  Delpharm exceeded 1 billion euros in revenue in 2023 and is investing heavily in injectable production capacities across its European and North American plants.

  actulabo.com · Feb 12, 2024
• Vaccination contre le Covid-19 : où en est le laboratoire Delpharm à Saint-Rémy-sur-Avre un an après

  Delpharm's Saint-Remy-sur-Avre site marks a successful year of manufacturing Pfizer-BioNTech Covid-19 vaccines.

  lechorepublicain.fr · Jan 28, 2022
• Catalent, Delpharm manufacturing sites win EU's blessing to produce millions of Pfizer, Moderna COVID-19 vaccine doses

  European regulators approved Delpharm and Catalent sites to significantly increase the production of Pfizer and Moderna COVID-19 vaccines.

  fiercepharma.com · Aug 25, 2021